Tagged with Education,

pharma The president of the Institut Pasteur talks about how they must build on their differentiating factors, with a focus on interdisciplinary research, why they are not a French institute with international partnerships, but an international institute that is based in France and how if there was one aspect he would…

pharma Omar Muñiz, President of ShareTech Group, discusses his company’s competitive positioning as a leading engineering, architecture, environmental consulting, and construction program management firm for the Puerto Rican life sciences industry. What are the main services ShareTech offers to the clients? We offer project planning & program management, environmental consulting, architectural…

pharma Agustín Rullán, Dean of the College of Engineering at UPR Mayagüez, discusses the institution’s latest developments in engineering courses and their applicability in a practical industrial setting for students to jumpstart their professional careers. As a leading engineering college with 4,300 undergraduates and 400 graduates, the College plays a very…

Pharma The Center for Pharmaceutical Engineering and Learning (CPEDaL) was established in 2006 as a ten year training program that is currently awaiting funding for the next five years. Carlos Velázquez, director of CPEDaL, explains how the Center introduces high school students to pharmaceutical engineering and their pioneering work in mixing…

Pharma Wanda Velez, president of the Puerto Rico Medical Association, discusses the history of the organization, which dates back to 1902. She also describes the Association’s voluntary role in contrast to the Colegio de Medicos, which by law is compulsory for all Puerto Rican physicians to join. Can you describe your…

pharma Prof. Dr. Murat Özgören, the architect behind the ambitious BioIzmir project, talks about its potential and how it intends to educate new talent to address critical future needs of the pharmaceutical industry. To begin, Dr. Özgören, could you give us an overview of the intent behind the BioIzmir project? The…

Pharma John Fernández van Cleve, Chancellor of UPRM, highlights the institution’s strong expertise in engineering and its application in the pharmaceutical and medical device fields. What are some of UPRM’s main assets? We are very blessed to have the best students in Puerto Rico. UPRM’s admission index is the highest on…

Pharma Centre International de Développement Pharmaceutique (CIDP) has pioneered cosmetic and pharmaceutical Research & Development in Mauritius, and is Mauritius’ flagship success story in the sector. Founded over 10 years ago, CIDP is an international CRO (Contract Research Organisation). As an entrepreneur and a pioneer, which opportunities did you see in Mauritius that…

Research Arnaud Lagesse, CEO of GML, the largest company in Mauritius and the third largest company in the Indian Ocean, discusses his company’s successful diversification into the life sciences sector, with the creation of GML Life. The history of GML has always been linked to the development of the Mauritian economy.…

Thailand The Government Pharmaceutical Organization’s Managing Director, Dr. Nopporn Cheanklin, tells PharmaBoardroom about its plans to launch 20 new products, its seaarch for medicines whose patents expire in the next few years, and the prospects for exports to Laos, Cambodia and Myanmar. What ambitions for growth does the organization have both in Thailand…

Monash University Professor Kenneth K. C. Lee, Head of the School of Pharmacy at Monash University Malaysia, discusses the institution’s position as a hub for health economics in the Asia Pacific region and explains the factors that will make the university a pharmaceutical leader.   There is a lot of competition in…

Pain Latin America continues to be in the spotlight at Grünenthal. The managing director for Mexico explains how the company is strengthening its product portfolio, working with stakeholders to create more awareness about pain treatment and on the good path to hit USD 100 million sales within the next four years.…